The CDC Director Search: A Sign of Shifting Priorities in Public Health? The search for a permanent director at the Centers for Disease Control and Prevention (CDC) is proving to be a complex undertaking. With President Trump struggling to find a suitable candidate, the role is currently held on an acting basis by Dr. Jay … Read more
The Sepsis Surge: Billing Practices and the Future of Healthcare Diagnostics Sepsis, a life-threatening condition arising from the body’s overwhelming response to an infection, is increasingly in the spotlight. The condition, likewise known as septicemia or septic shock, can originate from infections in the lungs, bladder, or anywhere else in the body. Massachusetts has seen … Read more
Iran Conflict: A Looming Shadow Over Pharmaceutical Supply Chains The recent escalation of conflict in the Middle East hasn’t yet caused widespread disruption to global pharmaceutical supplies, but experts warn that the potential for significant impact is growing. While current production in the immediate conflict zone represents a minor fraction of global output – just … Read more
The Future of Medicare: Automatic Enrollment and the Rise of Managed Care The debate over the future of Medicare is intensifying, with a potential shift towards automatic enrollment in Medicare Advantage plans gaining traction. Chris Klomp, President Trump’s Medicare director, recently revealed that the Centers for Medicare & Medicaid Services (CMS) is exploring the feasibility … Read more
Lilly’s Retatrutide: A New Era in Diabetes and Weight Management? Eli Lilly’s investigational drug, retatrutide, is generating significant buzz after demonstrating impressive results in a late-stage trial for Type 2 diabetes. The findings, released today, suggest a potential breakthrough in managing both blood sugar and weight – a historically challenging combination for individuals with the … Read more
Nursing Home Antipsychotic Misuse: A Looming Crisis and Potential Reforms Federal watchdog reports released this week underscore a persistent and troubling issue within the nursing home industry: the misuse of antipsychotic drugs and the inappropriate diagnosis of schizophrenia in residents with dementia. While not a new revelation, the latest findings from the Department of Health … Read more
FDA’s Top Infectious Disease Regulator Steps Down: What’s Next for Pandemic Preparedness? Washington D.C. – A key figure in the Food and Drug Administration’s (FDA) response to infectious disease threats is leaving the agency. Adam Sherwat, Director of the Office of Infectious Diseases within the FDA’s Center for Drug Evaluation and Research, will depart on … Read more
FDA’s Infectious Disease Chief Departs: What It Signals for Drug Approvals The Food and Drug Administration has seen another key departure, with Adam Sherwat, director of the Office of Infectious Diseases within the Center for Drug Evaluation and Research (CDER), announcing his last day is April 4th. This follows a broader trend of senior FDA … Read more
NIH Director Pledges Full Budget Spend Amid Grant Award Delays National Institutes of Health (NIH) Director Jay Bhattacharya has assured a House Appropriations subcommittee that the agency will spend its entire $48.7 billion budget for the 2026 fiscal year, despite a significant slowdown in grant awards. This commitment comes as concerns mount over potentially returning … Read more
Invivyd’s New CMO Signals a Shift in Infectious Disease Strategy Invivyd, Inc. Has appointed Michael Mina, M.D., Ph.D., as its Chief Medical Officer, a move that underscores a growing trend within the biopharmaceutical industry: a move from reactive pandemic response to proactive infectious disease prevention. This appointment, effective immediately, positions Invivyd to capitalize on the … Read more